HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pharmaco-resistance and side effects of antipsychotics associated with poor metabolizer phenotype for cytochrome P450 2D6 in a context of early-onset schizophrenia: A case report].

AuthorsA David, A Fernandez, M-L Menard, E Dor, V Bonnard-Couton, L Gugenheim, C Verstuyft, F Askenazy, S Thümmler
JournalL'Encephale (Encephale) Vol. 46 Issue 6 Pg. 507-508 (Dec 2020) ISSN: 0013-7006 [Print] France
Vernacular TitlePharmacorésistance et effets secondaires des antipsychotiques associés à un phénotype métaboliseur lent pour le cytochrome P450 2D6 dans un contexte de schizophrénie très précoce : à propos d’un cas clinique.
PMID32273136 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Cytochrome P-450 CYP2D6
Topics
  • Antipsychotic Agents (adverse effects)
  • Cytochrome P-450 CYP2D6 (genetics, therapeutic use)
  • Genotype
  • Humans
  • Phenotype
  • Schizophrenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: